Numerous studies have shown that changes in miR27a3p expression are associated with chemoresistance not only in bladder, gastric, and ovarian carcinoma but also in leukaemia, hepatocellular cancer, and breast cancer through the PI3K/Akt signalling pathway [94,95,96,97,98]. Here, AKT1 is linked to ovarian carcinoma.